Should Anthracyclines Still Be Regarded as the Cornerstone of Adjuvant Breast Cancer Therapy?
Are Anthracyclines the Cornerstone of Adjuvant Breast Cancer Therapy?
Jame Abraham, MD, FACP
20080007
2008 Jan 7
Should Anthracyclines Still Be Regarded as the Cornerstone of Adjuvant Breast Cancer Therapy?
2008 Jan 7, Jame Abraham, MD, FACP
Interesting presentations at SABCS questioned the role of anthracyclines as adjuvant therapy for breast cancer.
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
